• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® PROPATEN® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® PROPATEN® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER Back to Search Results
Catalog Number HT066080A
Device Problems Insufficient Information (3190); Material Split, Cut or Torn (4008)
Patient Problems Chest Pain (1776); Swelling/ Edema (4577)
Event Date 03/30/2021
Event Type  Injury  
Manufacturer Narrative
Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
The following was reported to gore via medwatch: on (b)(6) 2021, the patient underwent bilateral femoral endarterectomies and a right axillary to femoral bypass utilizing a gore® propaten® vascular graft.The patient tolerated the procedure and was discharged on (b)(6) 2021.On (b)(6) 2021, the patient noted swelling and chest pain and underwent reintervention.The patient received a right axillary cutdown and reportedly received additional stent(s).The physician stated the suture line remained intact but required 10 units of blood.Further information has been requested but has not been made available at this time.
 
Event Description
The following was reported to gore via medwatch: on (b)(6), 2021, the patient underwent bilateral femoral endarterectomies and a right axillary to femoral bypass utilizing a gore® propaten® vascular graft.The patient tolerated the procedure and was discharged on (b)(6), 2021.On (b)(6), 2021, the patient noted swelling and chest pain and underwent reintervention.An angiogram revealed a large right chest wall hematoma with active bleeding, occlusion of the patients axillary femoral and fem-fem bypass grafts, chronic occlusion of the inferior aspect of the abdominal aorta, pulmonary emphysema with no acute intrathoracic abnormalities, and no acute intra-abnormality.The patient received a right axillary cutdown, which correlated anatomically to where there was suspected graft disruption.The surgeon documented that there was a large tear in the middle of the graft, but the suture line remained completely intact.The physician was concerned that if the graft was repaired the patient would bleed again, so a stent was placed across the graft to ensure there was no blood flow through it.There were no pre-existing stents in the treatment zone prior to implant of the gore® propaten® vascular graft.It was reported that the patient required 10 units of blood.The patient was discharged on (b)(6), 2021 to a nursing home.The physician did not have any input on how the tear in the graft could have occurred.
 
Manufacturer Narrative
The following was added or updated to reflect additional information received: a4: patient weight - 120 lbs.B5: event description.B7: medical history - diabetes, hypertension, a-fib, pad.D4: catalog number, serial number, expiration date.H4: device manufacture date.H6: impact code - code 4642 added.H6: medical device problem code - updated to code 4008.H6: component code - code 525 added.H6: investigation findings - updated to code 213 g4: pma/510(k) number corrected to k062161.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® PROPATEN® VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
liam schultz
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key11850534
MDR Text Key251523875
Report Number2017233-2021-02018
Device Sequence Number1
Product Code DSY
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
K062161
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Risk Manager
Type of Report Initial,Followup
Report Date 12/10/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/19/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberHT066080A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received04/19/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/04/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage A
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient SexMale
Patient Weight54 KG
Patient RaceWhite
-
-